These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3920798)

  • 1. Pancreatic islet transplantation across partial major histocompatibility complex barriers.
    Georgiou HM; Mandel TE
    Transplant Proc; 1985 Apr; 17(2):1723-7. PubMed ID: 3920798
    [No Abstract]   [Full Text] [Related]  

  • 2. Importance of weak histocompatibility factors in survival of pancreatic islet transplants.
    Frangipane LG; Barker CF; Silvers WK
    Surg Forum; 1977; 28():294-6. PubMed ID: 103218
    [No Abstract]   [Full Text] [Related]  

  • 3. Pancreatic islet transplantation using H-2 incompatible multiple donors.
    Gotoh M; Maki T; Porter J; Monaco AP
    Transplant Proc; 1987 Feb; 19(1 Pt 2):957-9. PubMed ID: 3152648
    [No Abstract]   [Full Text] [Related]  

  • 4. Class I major histocompatibility complex antigen disparity is not a barrier to successful pancreatic islet cell engraftment.
    Jain K; Cai BR; Patel S; Anderson M; Miller D; Smith BH; Rubin AL; Suthanthiran M
    Transplant Proc; 1994 Dec; 26(6):3323-4. PubMed ID: 7998155
    [No Abstract]   [Full Text] [Related]  

  • 5. Manipulation of pancreatic islet cells in allotransplantation.
    Tze WJ; Tai J
    Transplant Proc; 1982 Dec; 14(4):714-23. PubMed ID: 6820204
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of antilymphocyte serum on crude pancreatic islet allograft survival.
    Gotoh M; Maki T; Satomi S; Porter J; Monaco AP
    Transplant Proc; 1987 Feb; 19(1 Pt 1):576-7. PubMed ID: 3152704
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolonged survival of intraportal versus subrenal capsular transplanted islet allografts.
    Gores PF; Rabe F; Sutherland DE
    Transplantation; 1987 May; 43(5):747-9. PubMed ID: 3107179
    [No Abstract]   [Full Text] [Related]  

  • 8. Survival of organ-cultured islet allografts in partially major histocompatibility complex (MHC)-compatible mice.
    Georgiou HM; Mandel TE
    Transplant Proc; 1984 Aug; 16(4):1062-3. PubMed ID: 6431667
    [No Abstract]   [Full Text] [Related]  

  • 9. Pancreatic islet allograft and xenograft survival in CD8+ T-lymphocyte-deficient recipients.
    Desai NM; Bassiri H; Odorico JS; Koller BH; Smithies O; Naji A; Barker CF; Markmann JF
    Transplant Proc; 1993 Feb; 25(1 Pt 2):961-2. PubMed ID: 8442280
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolongation of rat islet allografts with the use of ultraviolet irradiation, without immunosuppression.
    Hardy MA; Lau H; Reemtsma K
    Transplant Proc; 1984 Jun; 16(3):865-9. PubMed ID: 6233774
    [No Abstract]   [Full Text] [Related]  

  • 11. Consistent long-term allograft survival in murine pancreatic islet transplants without immunosuppression.
    Jain K; Cai BR; Patel S; Yang H; Smith BH; Suthanthiran M; Rubin AL
    Transplant Proc; 1994 Dec; 26(6):3492-3. PubMed ID: 7998243
    [No Abstract]   [Full Text] [Related]  

  • 12. Is the allograft response to islet transplantation antigens MHC restricted?
    Woehrle M; Bretzel RG; Federlin K
    Transplant Proc; 1993 Oct; 25(5):2863-4. PubMed ID: 8212266
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of host genetic background and microencapsulation on survival of rat-to-mouse islet xenografts.
    Weber C; Tanna A; Costanzo M; Ayres-Price J; Peterson L; Wicker L
    Transplant Proc; 1994 Jun; 26(3):1186-8. PubMed ID: 8029880
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultraviolet ray direct irradiation of pancreatic islets before transplantation.
    Rossi M; Dellagiacoma G; Castagna M; Radin S; Vecchioni R
    Transplant Proc; 1994 Dec; 26(6):3480-1. PubMed ID: 7998236
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts.
    Li H; Inverardi L; Molano RD; Pileggi A; Ricordi C
    Transplantation; 2003 Apr; 75(7):966-70. PubMed ID: 12698081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathymic xenogeneic pancreatic islet transplantation--induction of donor-specific unresponsiveness by MHC class II peptides.
    Zeng Y; Torres M; Wang Y; Montag A; Thistlethwaite JR
    Transplant Proc; 1995 Feb; 27(1):176-7. PubMed ID: 7878961
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonging survival of islet allografts by pretreating isolated islets with x-ray irradiation.
    Kimura T; Nakagawara G
    Transplant Proc; 1994 Aug; 26(4):2290-1. PubMed ID: 8066753
    [No Abstract]   [Full Text] [Related]  

  • 18. Fine specificity of class I MHC recognition in islet allografts.
    Ferguson D; Kohli N; Munn SR
    Transplant Proc; 1995 Dec; 27(6):3222. PubMed ID: 8539924
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of cryopreservation on islet allograft survival in diabetic rats.
    Höll E; Hering BJ; Bretzel RG; Federlin K
    Life Support Syst; 1985; 3 Suppl 1():675-9. PubMed ID: 3939684
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhancement of islet allograft survival in mice treated with MHC class I specific F(ab')2 alloantibody.
    Osorio RW; Ascher NL; Melzer JS; Stock PG
    Transplant Proc; 1994 Apr; 26(2):749. PubMed ID: 8171642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.